| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/19/2001 | CN1313400A Polypeptide-human ATP-dependent serine protein hydrolase 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313399A Polypeptide-human signalase 15 and polynucleotide for coding it |
| 09/19/2001 | CN1313397A Polypeptide-human ATP-dependent unwindase protein 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313396A Polypeptide-human transglutaminase 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313393A Polypeptide-human RNA unwindase 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313390A Polypeptide-protein kinase C-10 and polynucleotide for coding it |
| 09/19/2001 | CN1313389A Polypeptide-human lipoxidase 9 and polynucleotide for coding it |
| 09/19/2001 | CN1313387A Method for expression various proteins in plants with converted genes |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/19/2001 | CN1313338A Polypeptide motif bound with human CD95 and its polypeptide |
| 09/19/2001 | CN1313337A Polypeptide-zinc finger protein 10 and polynucleotide for coding it |
| 09/19/2001 | CN1313334A Polypeptide-human sarcoma protein 67 and polynucleotide for coding it |
| 09/19/2001 | CN1313329A Polypeptide-human excitatory amino acid rotor 16 and polynucleotide for coding it |
| 09/19/2001 | CN1313328A Polypeptide-human primary cadherin 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313327A Polypeptide-human junctional adhesion molecule 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313326A Polypeptide-human FD 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313324A Polypeptide-human hypoxia induction factor Lalpha subunit 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313321A Polypeptide-human cannabinol receptor protein 7 and polynucleotide for coding it |
| 09/19/2001 | CN1313320A Polypeptide-human cannabinol receptor protein 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313319A Polypeptide-human excitatory amino acid transporter 10 and polynucleotide for coding it |
| 09/19/2001 | CN1313318A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313317A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313316A Human protein able to suppress growth of cancer cells and its coding squence |
| 09/19/2001 | CN1313315A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313310A Polypeptide-human zinc finger protein 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313304A Polypeptide-human TNFR/NGFR protein 9 of structural domain containing cytochrome and polynucleotide for coding it |
| 09/19/2001 | CN1313302A Polypeptide-human zinc finger protein 27 and polynucleotide for coding it |
| 09/19/2001 | CN1313301A Polypeptide-human thyrocalcitonin 15 and polynucleotide for coding it |
| 09/19/2001 | CN1313300A Polypeptide-human interleukin conjugon 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313299A Polypeptide-human excitatory amino acid transporter 17 and polynucleotide for coding it |
| 09/19/2001 | CN1313293A Polypeptide-zinc finger protein 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313292A Polypeptide-amyloid precusor protein bindin 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313291A Polypeptide-ectodynamic protein arm Dhclalpha 47 and polynucleotide for coding it |
| 09/19/2001 | CN1313129A Process for preparing artificially synthetic polypeptide medicines |
| 09/19/2001 | CN1313108A Composite non-opium medicine for dropping drugs |
| 09/19/2001 | CN1313086A Use of fatty materials for prevention or reduction of microorganism adhere on skin and/or mucous membrane |
| 09/19/2001 | CN1071336C Compositions by using unbound MPL receptor for stimulating platelet production |
| 09/19/2001 | CN1071334C Glycopeptide antibiotic derivatives |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |
| 09/19/2001 | CN1071113C Compositions and processes for the sustained release of drugs |
| 09/18/2001 | US6291743 Transgenic plants expressing mutant geminivirus AC1 or C1 genes |
| 09/18/2001 | US6291668 Oligonucleotide derivatives |
| 09/18/2001 | US6291667 Method and composition for treatment of kaposi's sarcoma |
| 09/18/2001 | US6291663 TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma |
| 09/18/2001 | US6291662 A nucleic acid with serine protease inhibitor activity; therapy for emphysema, arthritis, glomerulonephritis, periodontial disease, muscular dystrophy, tumors, leukemia and sepsis |
| 09/18/2001 | US6291661 flt3-L mutants and method of use |
| 09/18/2001 | US6291659 A cdna present in fetal trophoblasts and adult circulating mono-nuclear cells; therapy for protecting the placenta from a maternal immune response (induction of immune tolerance) |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291653 A protein that regulates gastrointestinal physiology; therapy for nutritional homeostasis |
| 09/18/2001 | US6291648 Antitumor protein and corresponding gene sequence isolated from matsutake mushrooms |
| 09/18/2001 | US6291645 A polypeptide that modulates lymphocytes; diagnosis and therapy of cevical cancer, promotes wound healing and hair growth |
| 09/18/2001 | US6291644 A protein; anticarcinogenic agents, apoptotic agents |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291641 Hepatitis E virus antigens and uses therefor |
| 09/18/2001 | US6291640 Peptidomimetic inhibitors of the human cytomegalovirus protease |
| 09/18/2001 | US6291637 Peptide modulator of protein biosynthesis; for utilization as viricide |
| 09/18/2001 | US6291511 Biarylalkanoic acids as cell adhesion inhibitors |
| 09/18/2001 | US6291509 Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compound |
| 09/18/2001 | US6291495 Insulin sensitizer; and a sulfonylurea, a biguanide, or an alpha-glucosidase inhibitor. |
| 09/18/2001 | US6291452 Cholecystokinin antagonists. |
| 09/18/2001 | US6291443 Method of preventing and treating chemotherapy-induced alopecia with vitamin D3 or a derivative or analog or active metabolite thereof. |
| 09/18/2001 | US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject. |
| 09/18/2001 | US6291431 Methods and compositions for the treatment and prevention of Staphylococcal infections |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291429 Clock gene and gene product |
| 09/18/2001 | US6291428 Useful for promoting bone mineralization and osseointegration in the healing of, for example, orthopedic surgical procedures. |
| 09/18/2001 | US6291427 Lipoprotein-associated coagulation inhibition (laci) and sulfated polysaccharides, e.g. heparin, which exerts a synergistic anticoagulant action in whole plasma. |
| 09/18/2001 | US6291426 Strain of bacillus for controlling plant diseases and corn rootworm |
| 09/18/2001 | US6291424 Nitrosated and nitrosylated heme proteins |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6291236 Human cytomegalovirus DNA sequences |
| 09/18/2001 | US6291230 Galk promoter |
| 09/18/2001 | US6291223 Nucleotide sequence which codes an enzymatic polypeptide; for use in the treatment of alzheimer's disease, cancer and the processing of premature hormones |
| 09/18/2001 | US6291222 Carboxylesterase nucleic acid molecules and uses thereof |
| 09/18/2001 | US6291220 Polynucleotides encoding phosphatidylinositol 3-kinases |
| 09/18/2001 | US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof |
| 09/18/2001 | US6291211 Expressing heterologous polypeptides in cells; incubate cells with expression vectors, transform cells, express heterologous polypeptide |
| 09/18/2001 | US6291210 Differentiation inhibitor |
| 09/18/2001 | US6291207 Polynucleotide coding binding polypeptide; for use in prevention and treatment of viral diseases and development of viricides |
| 09/18/2001 | US6291206 BMP receptor proteins |
| 09/18/2001 | US6291199 Human phosphodiesterase type IVC, and its production and use |
| 09/18/2001 | US6291196 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 09/18/2001 | US6291173 MMSC2—an MMAC1 interacting protein |
| 09/18/2001 | US6291172 Diagnostic assay for diabetes mellitus based on mutational burden |
| 09/18/2001 | US6291161 Method for tapping the immunological repertiore |
| 09/18/2001 | US6291160 Method for producing polymers having a preselected activity |
| 09/18/2001 | US6291159 Isolating catalytic antibodies produced by expression vectors by synthesizing receptor-coding gene libraries containing a plurality of different receptor coding dna sequences, screen the libraries for polypeptides with desires specificity |
| 09/18/2001 | US6291158 Producing vector libraries capable of expressing variable heavy and light chain polypeptides by synthesizing variable chains, amplify and join the variable heavy chain to the light chain into expression vectors and screen the libraries |
| 09/18/2001 | US6290996 Administering an extract blend of the fruit of the emblica officinalis plant |
| 09/18/2001 | US6290987 Alkali metal alkyl sulfate, at least one membrane mimetic amphiphile, and at least one phospholipid. |
| 09/18/2001 | US6290972 Provides isolated human and murine cd40-l polypeptides that bind to the extracellular binding region of a cd40 receptor. |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |
| 09/18/2001 | US6290961 Method for treating dystonia with botulinum toxin type B |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | US6290958 Anti-flea epoxide hydrolase antibodies and uses thereof |
| 09/18/2001 | US6290957 Anti-IgE antibodies and method of improving polypeptides |
| 09/18/2001 | US6290953 May be a conjugate which includes a targeting portion adapted to target the conjugate to a specific cell type or anatomical location. |
| 09/18/2001 | US6290952 Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase |